Literature DB >> 20846473

Current strategies for the treatment of autoimmune diseases.

E Rosato, S Pisarri, F Salsano.   

Abstract

Autoimmune disease therapy may be considered a puzzle under construction. Current treatments for autoimmune diseases include physical therapy, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying anti-inflammatory drugs (DMARDs), anticytokine therapies, inhibition of intracellular-signaling pathways, costimulation inhibition, biological inhibitors of T cell function, B-cell anergy and depletion, regulatory T cells, stem cell transplantion. New biologic drugs that target specific cells or cytokines involved in the early inflammatory response started because of their improved efficacy and limited toxicity. The hematopoietic stem cell transplantation represents a possible therapeutic strategy for autoimmune diseases resistant to available treatments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846473

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  9 in total

1.  The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study.

Authors:  Qiang Mao; Hongting Jin; Fei Liao; Luwei Xiao; Di Chen; Peijian Tong
Journal:  Bone       Date:  2013-08-29       Impact factor: 4.398

2.  Caerulomycin A enhances transforming growth factor-β (TGF-β)-Smad3 protein signaling by suppressing interferon-γ (IFN-γ)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs).

Authors:  Rama Krishna Gurram; Weshely Kujur; Sudeep K Maurya; Javed N Agrewala
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

3.  Intravenous transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral head.

Authors:  Zhang-hua Li; Wen Liao; Xi-long Cui; Qiang Zhao; Ming Liu; You-hao Chen; Tian-shu Liu; Nong-le Liu; Fang Wang; Yang Yi; Ning-sheng Shao
Journal:  Int J Med Sci       Date:  2011-01-09       Impact factor: 3.738

4.  Intravenous transplantation of very small embryonic like stem cells in treatment of diabetes mellitus.

Authors:  Morteza Abouzaripour; Iraj Ragerdi Kashani; Parichehr Pasbakhsh; Nader Atlasy
Journal:  Avicenna J Med Biotechnol       Date:  2015 Jan-Mar

Review 5.  Antigen-based immunotherapy for autoimmune disease: current status.

Authors:  Darren Lowell Hirsch; Punita Ponda
Journal:  Immunotargets Ther       Date:  2014-12-16

6.  Favorable impact of long-term exercise on disease symptoms in pediatric patients with inflammatory bowel disease.

Authors:  Corinne Legeret; Laura Mählmann; Markus Gerber; Nadeem Kalak; Henrik Köhler; Edith Holsboer-Trachsler; Serge Brand; Raoul Furlano
Journal:  BMC Pediatr       Date:  2019-08-27       Impact factor: 2.125

7.  Saireito (114) Increases IC50 and Changes T-Cell Phenotype When Used in Combination with Prednisolone Therapy in Human Peripheral Blood Mononuclear Cells.

Authors:  Kyosuke Yamazaki; Anna Kiyomi; Shinobu Imai; Munetoshi Sugiura
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-28       Impact factor: 2.629

8.  Vaccine Immunotherapy for Celiac Disease.

Authors:  Antonio Di Sabatino; Marco V Lenti; Gino R Corazza; Carmen Gianfrani
Journal:  Front Med (Lausanne)       Date:  2018-06-26

Review 9.  Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment.

Authors:  Shirin Assar; Hosna Khazaei; Maryam Naseri; Fardous El-Senduny; Saeideh Momtaz; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  J Immunol Res       Date:  2021-06-24       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.